In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...

Opioid overdose deaths continued to rise among adolescents and young adults during a recent 5-year period, and synthetic ...

A subdivision of the American Diabetes Association has begun publishing a document that aims to provide comprehensive ...

Adults with treatment-resistant depression who received IV ketamine showed improvement in sadness-related symptoms ...

The FDA approved Dupixent for the treatment of adults with bullous pemphigoid, a rare skin disease often uncontrolled with ...

In this video, Chandler S. Cortina, MD, MS, FACS, discusses a cohort study that highlights the importance of additional research on breast cancer screening and treatment among transgender, nonbinary ...

Researchers have provided more evidence that mpox virus can be passed from a pregnant mother to her child. There remain ...

The American College of Lifestyle Medicine published new clinical guidance on lifestyle interventions for the treatment and ...

In this video, Paolo F. Caimi, MD, MBA, staff physician at Cleveland Clinic, discusses KITE-363, an anti-CD19/CD20 chimeric antigen receptor T-cell therapy, being studied for patients with ...

In the U.S. market, we currently have three newer multifocal IOLs approved for use: the Alcon Clareon PanOptix Pro, the ...

Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and ...

A coalition of health care organizations, called the Alliance for Healthcare from the Eye, is pushing for increased adoption ...